Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
P23 Labs operates as a CLIA high-complexity molecular diagnostics lab offering commercial nucleic acid-based tests for infectious diseases and preventative genetic testing. It received FDA Emergency Use Authorization for a SARS-CoV-2 RT‑PCR test and for home saliva collection for COVID‑19 testing, and commercially offers P23 Respiratory ONE, a multiplex respiratory pathogen panel, as well as other infectious disease and wellness-focused genetic tests[1][6][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on P23 Labs.